Brief: MaxCyte Q3 Gross Profit USD 5.2 Million
12/11/2025 21:05
Nov 12 (Reuters) - MaxCyte Q3 net income USD -12.4 million. Q3 operating expenses USD 19.4 million Q3 adjusted EBITDA USD -10 million vs. IBES estimate USD -10.4 million
Recent news on MaxCyte
See all newsCell-engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
Brief: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MaxCyte Inc reports results for the quarter ended June 30 - Earnings Summary
MaxCyte Q2 revenue beats estimates
MaxCyte Inc expected to post a loss of 9 cents a share - Earnings Preview